/home/corante/public_html/pipeline/ en-us derek-lowe@sbcglobal.net 2008-09-03T09:00:30-05:00 hourly 1 2000-01-01T12:00+00:00 http://pipeline.corante.com/archives/2008/09/03/direct_to_consumer_ads_wasted_money.php It’s a truism that half of all advertising dollars are wasted, but that no one buying the ads can be sure which half it is. Advertising from the drug companies is ubiquitous: how much of that is doing them no... 73526@/home/corante/public_html/pipeline/ Drug Prices 2008-09-03T09:00:30-05:00 http://pipeline.corante.com/archives/2008/03/18/a_solution_courtesy_of_the_mit_faculty.php Do drug discovery and drug marketing belong in the same company or not? That question’s been asked in several forms, but two MIT professors are taking it about as far as it can go. Stan Finkelstein and Peter Temin have... 73166@/home/corante/public_html/pipeline/ Business and Markets 2008-03-18T07:20:11-05:00 http://pipeline.corante.com/archives/2008/01/31/drugs_and_money.php Over at Megan McArdle's site at The Atlantic Monthly, there's been a run of posts on the pharmaceutical industry - touched off, I think, by this one from over here. Her readers are a diverse bunch, some of whom seem... 73074@/home/corante/public_html/pipeline/ Business and Markets 2008-01-31T08:21:44-05:00 http://pipeline.corante.com/archives/2008/01/28/laissezfaire.php Reader B.C. noted this on Ezra Klein’s blog over at The American Prospect, talking about Mark Warner’s Senate candidacy in Virginia. He quotes Warner as saying: ” We need to rationalize drug costs. I won't stand up here and bash... 73060@/home/corante/public_html/pipeline/ Drug Prices 2008-01-28T10:12:41-05:00 http://pipeline.corante.com/archives/2008/01/17/the_eu_suspects_no_one_and_suspects_everyone.php Thanks to a longtime reader in Germany, I have the scoop from the EU and the respected Frankfurter Allgemeine Zeitung newspaper. In an article about drug prices and drug approvals, titled “The European Pharmaceutical Industry Under Suspicion”, we find (my... 73029@/home/corante/public_html/pipeline/ Drug Prices 2008-01-17T09:39:20-05:00 http://pipeline.corante.com/archives/2008/01/10/drugs_and_money_and_how_it_feels.php Imagine that if you wanted to buy a car, you had to first visit a car consultant. This would be an expert who would place your order with a car dealer, after first looking over your transportation needs, financial status,... 73015@/home/corante/public_html/pipeline/ Business and Markets 2008-01-10T08:19:15-05:00 http://pipeline.corante.com/archives/2008/01/06/dollar_drugs_and_advertising.php Well, it's the first full working week of the year, so let's dive right into some controversy. There's an article on PloS Medicine on the amount that the drug industry spends on marketing. They at least try to avoid the... 72994@/home/corante/public_html/pipeline/ Drug Prices 2008-01-06T21:42:53-05:00 http://pipeline.corante.com/archives/2007/09/09/guess_that_market.php When a drug company starts off a new project, a lot of things go into the decision. Most of them are scientific decisions, but a big one that isn't is the projected market size. It's a business, and if you... 72670@/home/corante/public_html/pipeline/ Business and Markets 2007-09-09T20:16:45-05:00 http://pipeline.corante.com/archives/2007/07/24/godzilla_vs_mothra_relman_vs_epstein.php Arnold Relman is back. The co-author, with Marcia Angell, of The Truth About The Drug Companies, has a long review in The New Republic of Richard Epstein's new book on the industry, Overdose. Not everything in Epstein's book is right,... 72517@/home/corante/public_html/pipeline/ Drug Prices 2007-07-24T19:36:54-05:00 http://pipeline.corante.com/archives/2007/07/16/european_drugs_american_drugs.php I don't know how many people here in the US have noticed, but the European Community is getting worried about how well its member countries are doing in drug research. Their Pharmaceutical Forum group has met twice so far, trying... 72495@/home/corante/public_html/pipeline/ Business and Markets 2007-07-16T20:25:26-05:00 http://pipeline.corante.com/archives/2007/05/07/brazil_raises_the_pirate_flag.php Back in 2005, the government of Brazil threatened to break the patent on Abbott's HIV medication Kaletra if the price didn't come down (see here and here). But after a lot of arm-wrestling, a deal was reached. Now it's Merck's... 72284@/home/corante/public_html/pipeline/ Drug Prices 2007-05-07T09:18:31-05:00 http://pipeline.corante.com/archives/2006/07/19/fuzeons_fallout.php I wrote some time ago (Ay! Four years ago - have I been doing this for that long?) about the Roche/Trimeris HIV drug Fuzeon (T-20, enfuvirtide), and its costly manufacturing process. Roche built a factory in Colorado just to make... 62080@/home/corante/public_html/pipeline/ Infectious Diseases 2006-07-19T21:50:00-05:00 http://pipeline.corante.com/archives/2006/03/16/price_gouging_or_not.php Update: More on this issue from Jim Hu here. The New York Times ran a pretty heavy-duty article the other day on drug pricing. But for once, it wasn't the big companies that were getting pummelled. No, this time it... 53359@/home/corante/public_html/pipeline/ Drug Prices 2006-03-16T22:13:49-05:00 http://pipeline.corante.com/archives/2006/02/16/whats_it_worth_to_you.php So now we come (again) to the topic of cancer drug pricing. The New York Times ran an article on this the other day which has gotten a lot of attention. In it, Alex Berenson points out that prescriptions for... 48746@/home/corante/public_html/pipeline/ Cancer 2006-02-16T21:12:50-05:00 http://pipeline.corante.com/archives/2006/02/15/pfizer_takes_a_deep_breath.php I haven't mentioned Pfizer's inhaled insulin project in a while, but a few weeks ago they got the stuff approved, at (very) long last. The development of Exubera, which is certainly a cheerful brand name, has been anything but uplifting,... 48674@/home/corante/public_html/pipeline/ Diabetes and Obesity 2006-02-15T21:29:55-05:00